The global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period.
The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Targeted RNA Sequencing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Targeted RNA Sequencing market.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Key Features:
The report on Targeted RNA Sequencing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Targeted RNA Sequencing market. It may include historical data, market segmentation by Type (e.g., Exome Sequencing, Enrichment Sequencing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Targeted RNA Sequencing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Targeted RNA Sequencing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Targeted RNA Sequencing industry. This include advancements in Targeted RNA Sequencing technology, Targeted RNA Sequencing new entrants, Targeted RNA Sequencing new investment, and other innovations that are shaping the future of Targeted RNA Sequencing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Targeted RNA Sequencing market. It includes factors influencing customer ' purchasing decisions, preferences for Targeted RNA Sequencing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Targeted RNA Sequencing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Targeted RNA Sequencing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Targeted RNA Sequencing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Targeted RNA Sequencing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Targeted RNA Sequencing market.
Market Segmentation:
Targeted RNA Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Segmentation by application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted RNA Sequencing Market Size 2019-2030
2.1.2 Targeted RNA Sequencing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Targeted RNA Sequencing Segment by Type
2.2.1 Exome Sequencing
2.2.2 Enrichment Sequencing
2.2.3 Amplicon Sequencing
2.3 Targeted RNA Sequencing Market Size by Type
2.3.1 Targeted RNA Sequencing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted RNA Sequencing Market Size Market Share by Type (2019-2024)
2.4 Targeted RNA Sequencing Segment by Application
2.4.1 Research Institutes
2.4.2 Hospitals & Clinics
2.4.3 Biotechnology Company
2.4.4 Diagnostic Lab
2.5 Targeted RNA Sequencing Market Size by Application
2.5.1 Targeted RNA Sequencing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted RNA Sequencing Market Size Market Share by Application (2019-2024)
3 Targeted RNA Sequencing Market Size by Player
3.1 Targeted RNA Sequencing Market Size Market Share by Players
3.1.1 Global Targeted RNA Sequencing Revenue by Players (2019-2024)
3.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Targeted RNA Sequencing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Targeted RNA Sequencing by Regions
4.1 Targeted RNA Sequencing Market Size by Regions (2019-2024)
4.2 Americas Targeted RNA Sequencing Market Size Growth (2019-2024)
4.3 APAC Targeted RNA Sequencing Market Size Growth (2019-2024)
4.4 Europe Targeted RNA Sequencing Market Size Growth (2019-2024)
4.5 Middle East & Africa Targeted RNA Sequencing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Targeted RNA Sequencing Market Size by Country (2019-2024)
5.2 Americas Targeted RNA Sequencing Market Size by Type (2019-2024)
5.3 Americas Targeted RNA Sequencing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted RNA Sequencing Market Size by Region (2019-2024)
6.2 APAC Targeted RNA Sequencing Market Size by Type (2019-2024)
6.3 APAC Targeted RNA Sequencing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Targeted RNA Sequencing by Country (2019-2024)
7.2 Europe Targeted RNA Sequencing Market Size by Type (2019-2024)
7.3 Europe Targeted RNA Sequencing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted RNA Sequencing by Region (2019-2024)
8.2 Middle East & Africa Targeted RNA Sequencing Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted RNA Sequencing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Targeted RNA Sequencing Market Forecast
10.1 Global Targeted RNA Sequencing Forecast by Regions (2025-2030)
10.1.1 Global Targeted RNA Sequencing Forecast by Regions (2025-2030)
10.1.2 Americas Targeted RNA Sequencing Forecast
10.1.3 APAC Targeted RNA Sequencing Forecast
10.1.4 Europe Targeted RNA Sequencing Forecast
10.1.5 Middle East & Africa Targeted RNA Sequencing Forecast
10.2 Americas Targeted RNA Sequencing Forecast by Country (2025-2030)
10.2.1 United States Targeted RNA Sequencing Market Forecast
10.2.2 Canada Targeted RNA Sequencing Market Forecast
10.2.3 Mexico Targeted RNA Sequencing Market Forecast
10.2.4 Brazil Targeted RNA Sequencing Market Forecast
10.3 APAC Targeted RNA Sequencing Forecast by Region (2025-2030)
10.3.1 China Targeted RNA Sequencing Market Forecast
10.3.2 Japan Targeted RNA Sequencing Market Forecast
10.3.3 Korea Targeted RNA Sequencing Market Forecast
10.3.4 Southeast Asia Targeted RNA Sequencing Market Forecast
10.3.5 India Targeted RNA Sequencing Market Forecast
10.3.6 Australia Targeted RNA Sequencing Market Forecast
10.4 Europe Targeted RNA Sequencing Forecast by Country (2025-2030)
10.4.1 Germany Targeted RNA Sequencing Market Forecast
10.4.2 France Targeted RNA Sequencing Market Forecast
10.4.3 UK Targeted RNA Sequencing Market Forecast
10.4.4 Italy Targeted RNA Sequencing Market Forecast
10.4.5 Russia Targeted RNA Sequencing Market Forecast
10.5 Middle East & Africa Targeted RNA Sequencing Forecast by Region (2025-2030)
10.5.1 Egypt Targeted RNA Sequencing Market Forecast
10.5.2 South Africa Targeted RNA Sequencing Market Forecast
10.5.3 Israel Targeted RNA Sequencing Market Forecast
10.5.4 Turkey Targeted RNA Sequencing Market Forecast
10.5.5 GCC Countries Targeted RNA Sequencing Market Forecast
10.6 Global Targeted RNA Sequencing Forecast by Type (2025-2030)
10.7 Global Targeted RNA Sequencing Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher Targeted RNA Sequencing Product Offered
11.1.3 Thermo Fisher Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Targeted RNA Sequencing Product Offered
11.2.3 Illumina Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Roche Holdings
11.3.1 Roche Holdings Company Information
11.3.2 Roche Holdings Targeted RNA Sequencing Product Offered
11.3.3 Roche Holdings Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Roche Holdings Main Business Overview
11.3.5 Roche Holdings Latest Developments
11.4 BGI
11.4.1 BGI Company Information
11.4.2 BGI Targeted RNA Sequencing Product Offered
11.4.3 BGI Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 BGI Main Business Overview
11.4.5 BGI Latest Developments
11.5 Eurofins
11.5.1 Eurofins Company Information
11.5.2 Eurofins Targeted RNA Sequencing Product Offered
11.5.3 Eurofins Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Eurofins Main Business Overview
11.5.5 Eurofins Latest Developments
11.6 LabCorp
11.6.1 LabCorp Company Information
11.6.2 LabCorp Targeted RNA Sequencing Product Offered
11.6.3 LabCorp Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 LabCorp Main Business Overview
11.6.5 LabCorp Latest Developments
11.7 Berry Genomics
11.7.1 Berry Genomics Company Information
11.7.2 Berry Genomics Targeted RNA Sequencing Product Offered
11.7.3 Berry Genomics Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Berry Genomics Main Business Overview
11.7.5 Berry Genomics Latest Developments
11.8 Macrogen
11.8.1 Macrogen Company Information
11.8.2 Macrogen Targeted RNA Sequencing Product Offered
11.8.3 Macrogen Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Macrogen Main Business Overview
11.8.5 Macrogen Latest Developments
11.9 GENEWIZ
11.9.1 GENEWIZ Company Information
11.9.2 GENEWIZ Targeted RNA Sequencing Product Offered
11.9.3 GENEWIZ Targeted RNA Sequencing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 GENEWIZ Main Business Overview
11.9.5 GENEWIZ Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
